Tag: hepatocellular carcinoma risk factors

A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...

In recent years, glucagon-like peptide 1 receptor agonists (GLP1RAs) have emerged as a transformative class of therapeutics for managing type ...

Steatotic liver diseases, which include conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD), are emerging ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a critical area of research within hepatology, presenting a complex ...

Mangiferin: A Novel Hepatoprotective for Liver Cirrhosis The human liver is a remarkable organ, essential for various systemic functions, including ...

Recent advancements in hepatology have underscored the significance of understanding hepatitis B virus (HBV) and its variants in relation to ...

In a remarkable stride toward revolutionizing liver disease diagnostics, researchers have unveiled a pioneering 3D multiparametric ultrasound imaging technique that ...

Hepatocellular carcinoma (HCC), a primary malignancy of the liver, poses a significant threat to patients with chronic liver disease (CLD). ...

In an unprecedented leap forward in understanding hepatitis B virus (HBV) biology, a team of researchers has uncovered remarkable heterogeneity ...

In a groundbreaking study poised to redefine therapeutic approaches to liver fibrosis, researchers have unveiled the pivotal role of microRNA ...